Astrocytic Calcium and cAMP in Neurodegenerative Diseases

被引:21
|
作者
Sobolczyk, Marta [1 ]
Boczek, Tomasz [1 ]
机构
[1] Med Univ, Fac Hlth Sci, Dept Mol Neurochem, Lodz, Poland
关键词
astrocyte; calcium; cyclic AMP (cAMP); neurodegeneration; Parkinson's disease; PKA; adenylyl cyclases; Alzheimer's disease; APOLIPOPROTEIN-E; CORTICAL ASTROCYTES; ALZHEIMERS-DISEASE; BETA-ADRENOCEPTORS; INTRACELLULAR CA2+; PARKINSONS-DISEASE; GLUTAMATE RELEASE; SUBSTANTIA-NIGRA; NMDA RECEPTORS; INCREASES CAMP;
D O I
10.3389/fncel.2022.889939
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It is commonly accepted that the role of astrocytes exceeds far beyond neuronal scaffold and energy supply. Their unique morphological and functional features have recently brough much attention as it became evident that they play a fundamental role in neurotransmission and interact with synapses. Synaptic transmission is a highly orchestrated process, which triggers local and transient elevations in intracellular Ca2+, a phenomenon with specific temporal and spatial properties. Presynaptic activation of Ca2+-dependent adenylyl cyclases represents an important mechanism of synaptic transmission modulation. This involves activation of the cAMP-PKA pathway to regulate neurotransmitter synthesis, release and storage, and to increase neuroprotection. This aspect is of paramount importance for the preservation of neuronal survival and functionality in several pathological states occurring with progressive neuronal loss. Hence, the aim of this review is to discuss mutual relationships between cAMP and Ca2+ signaling and emphasize those alterations at the Ca2+/cAMP crosstalk that have been identified in neurodegenerative disorders, such as Alzheimer's and Parkinson's disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] The lysosome and neurodegenerative diseases
    Zhang, Lisha
    Sheng, Rui
    Qin, Zhenghong
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2009, 41 (06) : 437 - 445
  • [42] Prions and neurodegenerative diseases
    Hope, J
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (05) : 568 - 574
  • [43] Mitoepigenetics and neurodegenerative diseases
    Stoccoro, A.
    Nicoli, V.
    Gallo, R.
    Mosca, L.
    Baldacci, F.
    Del Gamba, C.
    Cereda, C.
    Palmieri, I.
    Gagliardi, S.
    Smith, A. R.
    Lunnon, K.
    Coppede, F.
    Migliore, L.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1738 - 1739
  • [44] Driving and neurodegenerative diseases
    Ergun Y. Uc
    Matthew Rizzo
    Current Neurology and Neuroscience Reports, 2008, 8
  • [45] NEUROTOXINS AND NEURODEGENERATIVE DISEASES
    TIPTON, KF
    MCBEAN, GJ
    DAVEY, SP
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S65 - S65
  • [46] Glycosaminoglycans in Neurodegenerative Diseases
    Jin, Weihua
    Zhang, Fuming
    Linhardt, Robert J.
    ROLE OF GLYCOSYLATION IN HEALTH AND DISEASE, 2021, 1325 : 189 - 204
  • [47] Cannabinoids and Neurodegenerative Diseases
    Romero, Julian
    Martinez-Orgado, Jose
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 440 - 450
  • [48] Epilepsy in neurodegenerative diseases
    Neri, Sabrina
    Mastroianni, Giovanni
    Gardella, Elena
    Aguglia, Umberto
    Rubboli, Guido
    EPILEPTIC DISORDERS, 2022, 24 (02) : 249 - 273
  • [49] Hallmarks of neurodegenerative diseases
    Wilson III, David M.
    Cookson, Mark R.
    Van Den Bosch, Ludo
    Zetterberg, Henrik
    Holtzman, David M.
    Dewachter, Ilse
    CELL, 2023, 186 (04) : 693 - 714
  • [50] Polyphenols and neurodegenerative diseases
    Barreto, George E.
    Guedes, Rubem C. A.
    NUTRITIONAL NEUROSCIENCE, 2012, 15 (03) : 92 - 93